Molecular classification of renal tumors by gene expression profiling.

[1]  M. Kattan,et al.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma , 2006, Annals of Surgical Oncology.

[2]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[3]  F. Marshall.  Expression of Alpha-Methylacyl-CoA Racemase in Papillary Renal Cell Carcinoma , 2004 .

[4]  Ximing J. Yang,et al.  Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma , 2004, The American journal of surgical pathology.

[5]  T. Speed,et al.  GOstat: find statistically overrepresented Gene Ontologies within a group of genes. , 2004, Bioinformatics.

[6]  Robert E. Brown,et al.  Immunohistochemical Detection of P504S in Primary and Metastatic Renal Cell Carcinomas , 2004, Applied immunohistochemistry & molecular morphology : AIMM.

[7]  A. Yu,et al.  Expression of claudin-7 and -8 along the mouse nephron. , 2004, American journal of physiology. Renal physiology.

[8]  Ximing J. Yang,et al.  Expression of Alpha-Methylacyl-CoA Racemase in Papillary Renal Cell Carcinoma , 2004, The American journal of surgical pathology.

[9]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[10]  K. Inoki,et al.  TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.

[11]  R. Figlin,et al.  Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  William R Sellers,et al.  TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.

[13]  S. Richard,et al.  Inactivation of BHD in sporadic renal tumors. , 2003, Cancer research.

[14]  Cheng Tc,et al.  Angiomyolipoma of kidney as a part of tuberous sclerosis complex. , 2003 .

[15]  C. Collesi,et al.  The Ron Proto-oncogene Product Is a Phenotypic Marker of Renal Oncocytoma , 2003, The American journal of surgical pathology.

[16]  Joanna H Shih,et al.  Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Terris,et al.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. , 2003, The American journal of pathology.

[18]  F. Marshall,et al.  Beta Defensin-1, Parvalbumin, and Vimentin: A Panel of Diagnostic Immunohistochemical Markers for Renal Tumors Derived From Gene Expression Profiling Studies Using cDNA Microarrays , 2003, The American journal of surgical pathology.

[19]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[20]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[21]  Ximing J. Yang,et al.  Molecular subclassification of kidney tumors and the discovery of new diagnostic markers , 2003, Oncogene.

[22]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  W. Linehan,et al.  Renal Tumors in the Birt-Hogg-Dubé Syndrome , 2002, The American journal of surgical pathology.

[24]  P. Verroust,et al.  Megalin and cubilin, role in proximal tubule function and during development , 2002, Pediatric Nephrology.

[25]  F. Marshall,et al.  Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. , 2002, The Journal of urology.

[26]  Mark A. Rubin,et al.  Expression profiling of human renal carcinomas with functional taxonomic analysis , 2002, BMC Bioinformatics.

[27]  Maria Merino,et al.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.

[28]  D. Kalaitzidis,et al.  Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer , 2002 .

[29]  A. El‐Naggar,et al.  Biological significance of c-met over expression in papillary renal cell carcinoma. , 2002, The Journal of urology.

[30]  Kathy Pfeiffer,et al.  Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.

[31]  R. Motzer,et al.  Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Mahul B. Amin,et al.  Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases , 2002, The American journal of surgical pathology.

[33]  D. Brat,et al.  Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. , 2002, Journal of the American Academy of Dermatology.

[34]  D. Kalaitzidis,et al.  Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer. , 2002, Cancer letters.

[35]  L. Álvarez-Vallina,et al.  Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy , 2001, Cancer Immunology, Immunotherapy.

[36]  M Vingron,et al.  Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31 , 500-Element cDNA Array , 2001 .

[37]  K. Furge,et al.  Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Scarpa,et al.  Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma , 2001, Modern Pathology.

[39]  M. Kattan,et al.  A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.

[40]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[41]  F. Marshall,et al.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. , 2001, The American journal of pathology.

[42]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Myles,et al.  The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation. , 2001, The Canadian journal of urology.

[44]  R. Figlin,et al.  Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  H. Höfler,et al.  Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. , 2001, The American journal of pathology.

[46]  A. Weaver,et al.  Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population. , 2001, Genetic testing.

[47]  R. Chen,et al.  Laparoscopic cryoablation of renal masses. , 2000, The Urologic clinics of North America.

[48]  S. Tickoo,et al.  Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma , 2000, The American journal of surgical pathology.

[49]  H. Moch,et al.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.

[50]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[51]  R. Ve,et al.  Contemporary approach to the classification of renal epithelial tumors. , 2000 .

[52]  S. Reed,et al.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. , 2000, Cancer research.

[53]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[54]  J. Petros,et al.  Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma , 1999, BJU international.

[55]  Y. Collan,et al.  Cathepsin H expression distinguishes oncocytomas from renal cell carcinomas. , 2000, Anticancer research.

[56]  V. Reuter,et al.  Contemporary approach to the classification of renal epithelial tumors. , 2000, Seminars in oncology.

[57]  W. Linehan,et al.  Histopathology and molecular genetics of renal tumors toward unification of a classification system. , 1999, The Journal of urology.

[58]  J. Coindre,et al.  Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. , 1999, The American journal of surgical pathology.

[59]  M. Rubin,et al.  Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.

[60]  H. Brewer,et al.  Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  F. Marincola,et al.  Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[63]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[64]  P. Choyke,et al.  Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. , 1998, Cancer research.

[65]  J. Dickinson,et al.  Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy. , 1997, Biochemical pharmacology.

[66]  Y. Tomita,et al.  Erratum to ‘MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host’ [Cancer Lett. 109 (1996), 15–21] , 1997 .

[67]  P. Bugert,et al.  Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[68]  D. Bostwick,et al.  Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. , 1996, The Journal of urology.

[69]  Y. Homma,et al.  INCREASED INCIDENTAL DETECTION AND REDUCED MORTALITY IN RENAL CANCER—RECENT RETROSPECTIVE ANALYSIS AT EIGHT INSTITUTIONS , 1995, International journal of urology : official journal of the Japanese Urological Association.

[70]  A. Norton,et al.  Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.

[71]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[72]  J. Weber,et al.  Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease , 1992, Nature genetics.

[73]  R. Bindels,et al.  Calbindin-D9k and parvalbumin are exclusively located along basolateral membranes in rat distal nephron. , 1991, Journal of the American Society of Nephrology : JASN.

[74]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[75]  M. Ortmann,et al.  Renal oncocytoma , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[76]  S. Povey,et al.  EVIDENCE THAT THE GENE FOR TUBEROUS SCLEROSIS IS ON CHROMOSOME 9 , 1987, The Lancet.

[77]  R. C. Nairn,et al.  Renal tubular antigens in kidney tumors , 1972, Cancer.

[78]  K BOCZKOWSKI,et al.  CHROMOSOMAL ENDOREDUPLICATION IN A CASE OF TURNER'S SYNDROME WITH 44/XX KARYOTYPE. , 1965, Lancet.